Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
April 2, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
August 1, 2026
Conditions
Infantile Hemangioma
Interventions
DRUG
propranolol
different dose
Trial Locations (1)
610041
West China Hospital of Sichuan University, Chengdu
All Listed Sponsors
lead
West China Hospital
OTHER
NCT06798363 - Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma | Biotech Hunter | Biotech Hunter